摘要
幽门螺杆菌疫苗是预防和治疗幽门螺杆菌感染引起的上消化道疾病的有效途径。而疫苗的研制是关键和基础。一种好的疫苗完全可结束人与幽门螺杆菌共存的现象。
出处
《微生物学免疫学进展》
2003年第1期42-46,共5页
Progress In Microbiology and Immunology
参考文献35
-
1Mukhopadhyay P.Gastic cancer and Lymphorna [ M].In:Westblom T-U,Czinn SJ,Nedrud JG,eds.Curr Top Microbiol Immunol.Berlin:Springer Verlag 1999,57-69. 被引量：1
-
2Jorgensen M,Dasklopoulos G,Warburton V,et al.Multiple strain colonization and metreonidazole resistance in Helicobacter pyloriinfected patients:Identification from sequential and multiple biopsy specimens[J].J Infect Dis 1996,174:631-635. 被引量：1
-
3Matsui H,Kubo Y,Ninomiya T,et al.Recurrence of gastric ulcer dependent upon strain differences of Helicobacter pylori in ureaseB gene.Dig.Dis.Sci.2000; 45:49-54. 被引量：1
-
4Mattapallil JJ,Dandekar S,Canfield DR,et al.A predominant Th1 type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques [J].Gastroenterology 2000,118:307-315. 被引量：1
-
5Saldinger PF,Porta N,Launois P,et al.Immunization of BALB/c mice with Helicobacter ureasse B induces a T helper 2 response absent in Helicobaceter infection [J].Gastroenterology 1998,115:891-897. 被引量：1
-
6Lee A,Fox JG,Otto G,et al.A small animal model of human Helicobacter pylori active chronic gastritis [J].Gastroenterology1990,99(5):1315-1323. 被引量：1
-
7Fox JG,Correa P,Taylor NS,et al.Helicobacter mustelae-associated gastritis in ferrets:An animal model of Helicobacter pylori gastritis in humans[J].Gastroenterology 1990,99(2):352-361. 被引量：1
-
8Dubios A,Fiala N,Heman-Ackah L,et al.Natural gastric infection with Helicobacter pylori in monkeys:a model for spiral bacteria infection in humans[J].Gastroenterology 1994,106(6):1405-1417. 被引量：1
-
9Marchetti M,Arico B,Burroni D,et al.Development of a mouse model of Helicobacter pylori infection that mimics human disease [J].Science 1995,267(5204):1655-1658. 被引量：1
-
10Nedrud JG.Animal models for gastric Helicobacter immunology and vaccine studies[J].FEMS Immunol Med Microbiol 1999,24(2):243-250. 被引量：1
同被引文献25
-
1周红莉,郭丽,王健伟,洪涛.粘膜免疫佐剂研究进展[J].中国生物工程杂志,2006,26(3):83-88. 被引量：13
-
2Das J C,Paul N. Epidemiology and pathophysiology of Helicobacter py- lori infection in children[J]. Indian J Pediatr,2007;74(3) : 287-290. 被引量：1
-
3Sougioultzis S, Lee C K, Alsahli Met al. Safety and efficacy of E. coli enterotoxin adjuvant for urease-based rectal immunization against He- licobaeter pylori [ J ]. Vaccine,2002 ;21 (3-4) : 194-201. 被引量：1
-
4Wotherspoon A C, Doglioni C, Diss T C et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tis- sue type after eradication of Helicobacter pylori [ J ]. Lancet, 1993 ;342 (8871) :575-577. 被引量：1
-
5Robinson K, Argent R H, Atherton J C. The inflammatory and immune response to Helicobaeter pylori infection[ J]. Best Praet Res Clin Gas- troentero1,2007 ;21 (2) :237-259. 被引量：1
-
6Blaser M J, 'Atherton J C. Helicobacter pylori persistence: biology and disease[ J]. J Clin Invest ,2004 ; 113 ( 3 ) : 321-333. 被引量：1
-
7Czinn S J, Nedrud J G. Oral immunization against Helicobacter pylori [ J ]. Infect Immun, 1991 ;59 ( 7 ) : 2359 -2363. 被引量：1
-
8Chen M, Lee A, Hazell S. Immunisation against gastric helicobacter infection in a mouse/Helicobacter felis model [ J ]. Lancet, 1992;339 (8501) :1120-1121. 被引量：1
-
9Gottwein J M, Blanchard T G, Targoni O Set al. Protective anti-Heli- cobacter immunity is induced with aluminum hydroxide or complete Freund' s adjuvant by systemic immunization [ J ]. J Infect Dis, 2001 ; 184(3) :308-314. 被引量：1
-
10Summerton N A, Welch R W, Bondoc Let al. Toward the develop- ment of a stable, freeze-dried formulation of Helieobacter pylori kill- ed whole cell vaccine adjuvanted with a novel mutant of Escherichiacoli heat-labile toxin [ J ]. Vaccine ,2010 ;28 (5) : 1404-1411. 被引量：1
二级引证文献6
-
1谢元元,刘文娜,戴光荣.评述根除幽门螺杆菌策略的演变和新进展[J].现代消化及介入诊疗,2013,18(5):294-298. 被引量：2
-
2吴美泼.中医辩证加减治疗脾胃虚寒型幽门螺杆菌感染慢性胃炎的临床观察[J].现代诊断与治疗,2016,27(3):429-430. 被引量：12
-
3李超,张振玉.幽门螺杆菌感染根治成功后复发的研究进展[J].世界华人消化杂志,2016,24(13):2019-2024. 被引量：4
-
4孙楠,张荣光,段广才,陈帅印,彭晓燕,范清堂,郗园林.幽门螺杆菌lpp20基因在食品级乳酸菌中的表达及免疫活性鉴定[J].郑州大学学报（医学版）,2016,51(4):478-482.
-
5阴瑞瑞,王琦.探索新型防治幽门螺杆菌感染方法[J].临床医药文献电子杂志,2018,5(42):196-198.
-
6李欣,马艳,陈小玉.新序贯疗法治疗难治性Hp感染的效果分析[J].湖南师范大学学报（医学版）,2017,14(4). 被引量：3
-
1相泽益男,包玉生.生物传感器的现状及前景[J].国外医学（生物医学工程分册）,1993,16(2):96-99.
-
2罗克桓,王奇璐.造血细胞冷冻保存的现状及前景[J].国外医学（输血及血液学分册）,1991,14(5):268-273. 被引量：7
-
3孙宁宁,王绪凯.骨组织工程支架材料的研究进展[J].国际生物医学工程杂志,2007,30(4):251-254. 被引量：3
-
4张骁,束梅英.HIV疫苗的研究现状及前景[J].中国制药信息,2000,16(3):2-4. 被引量：1
-
5顾潇,陈必良.羊水多潜能干细胞的研究现状及前景展望[J].中国妇幼健康研究,2011,22(1):116-118.
-
6刘岱青.幽门螺杆菌及其疫苗研究现状及前景[J].国外医学（微生物学分册）,1999,22(4):21-24.
-
7李晓东,程智慧,于燕.转基因植物疫苗的研究现状及前景[J].西北农业大学学报,2001,29(1):126-128. 被引量：1
-
8刘靖祎,叶茂昌.皮肤创伤修复的研究现状及前景[J].口腔医学,2010,30(9):561-563. 被引量：3
-
9陈莉,杜锡光,赵保中,景遐斌,陈学思.聚羟基乙酸及其共聚物[J].高分子通报,2003(1):18-24. 被引量：27
-
10刘岱青,张振华.幽门螺杆菌与疫苗研究现状及前景[J].中华医学信息导报,1998,0(5):2-3. 被引量：1
